2006
DOI: 10.1016/j.jcv.2005.05.005
|View full text |Cite
|
Sign up to set email alerts
|

A multi-centre pilot proficiency programme to assess the quality of molecular detection of respiratory viruses

Abstract: The first proficiency panel showed that in general all participants performed well. Although, it also highlights areas for improvement for all participants in order to generate robust results for use in clinical diagnostics.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
16
0

Year Published

2006
2006
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 24 publications
(16 citation statements)
references
References 25 publications
0
16
0
Order By: Relevance
“…In addition, formal external quality assessment schemes and proficiency panels play a complementary role in monitoring the specificity and sensitivity of assays across laboratories. [9][10][11] The National Institute for Biological Standards and Control (NIBSC) was established in the UK to safeguard and enhance public health through the standardisation and control of biological products used in medicine. The institute prepares and distributes standards and reference materials used to determine the purity and potency of biological medicinal products in its capacity as a WHO Laboratory for International Standards.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, formal external quality assessment schemes and proficiency panels play a complementary role in monitoring the specificity and sensitivity of assays across laboratories. [9][10][11] The National Institute for Biological Standards and Control (NIBSC) was established in the UK to safeguard and enhance public health through the standardisation and control of biological products used in medicine. The institute prepares and distributes standards and reference materials used to determine the purity and potency of biological medicinal products in its capacity as a WHO Laboratory for International Standards.…”
Section: Introductionmentioning
confidence: 99%
“…Discovery of hMPV was delayed by difficulties in establishing growth in routine viral culture cells (van den Hoogen et al, 2001). The development of hMPV specific monoclonal antibodies allows detection in a direct specimen smear or after tissue culture but antigen detection methods are less sensitive than molecular methods (Ebihara et al, 2005;Ingram et al, 2006;Landry et al, 2005;Percivalle et al, 2005).…”
Section: Introductionmentioning
confidence: 99%
“…The development of hMPV specific monoclonal antibodies allows detection in a direct specimen smear or after tissue culture but antigen detection methods are less sensitive than molecular methods (Ebihara et al, 2005;Ingram et al, 2006;Landry et al, 2005;Percivalle et al, 2005). Several groups have described reverse-transcription polymerase chain reaction (PCR) based assays to detect hMPV, mostly targeting the fusion, nucleoprotein, or polymerase genes though the matrix and 5 non-coding region have also been targeted (Bouscambert-Duchamp et al, 2005;Deffrasnes et al, 2005;Greensill et al, 2003;Gunson et al, 2005;Kuypers et al, 2005;Mackay et al, 2003;Maertzdorf et al, 2004;Templeton et al, 2006;van den Hoogen et al, 2003). The increasing number of real-time PCR (RT-PCR) methods reflects the clinical demand for the introduction of routine testing for hMPV in diagnostic laboratories.…”
Section: Introductionmentioning
confidence: 99%
“…One of the best ways of assessing this ability is through participation in external quality assessment (EQA) programmes (Meijer et al, 2005;Templeton et al, 2006;Valette and Aymard, 2002). An EQA study was organ- ised by Quality Control for Molecular Diagnostics (QCMD) (http://www.qcmd.org) in collaboration with the European Influenza Surveillance Scheme (EISS) and the European Society for Clinical Virology (ESCV).…”
Section: Introductionmentioning
confidence: 99%